Browse Title Index

Issue Title
Vol 18, No 6 (2011) Lymphedema in Canada: a qualitative study to help develop a clinical, research, and education strategy Abstract   PDF   HTML
P. Hodgson, A. Towers, D.H. Keast, A. Kennedy, R. Pritzker, J. Allen
Vol 19, No 3 (2012) Lymphoepithelioma-like carcinoma of the breast: a diagnostic and therapeutic challenge Abstract   PDF   HTML
R. Dinniwell, W.M. Hanna, M. Mashhour, R.S. Saad, G.J. Czarnota
Vol 17, No 2 (2010) Lymphovascular invasion as a predictive factor for muscle-invasive bladder cancer and its importance in a bladder-conservation treatment group Details   PDF
H. Tokgoz, B. Erol
Vol 20, No 5 (2013) Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma Abstract   PDF   HTML
M. Bhat, M. Hassanain, E. Simoneau, G. N. Tzimas, P. Chaudhury, M. Deschenes, D. Valenti, P. Ghali, P. Wong, T. Cabrera, J. Barkun, J.I. Tchervenkov, P. Metrakos
Vol 19, No 1 (2012) Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time Abstract   PDF   HTML
D. Fruci, M. Benevolo, L. Cifaldi, S. Lorenzi, E. Lo Monaco, E. Tremante, P. Giacomini
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Making a difference with teamwork Abstract   PDF   HTML
V. Hirsh
Vol 20, No 6 (2013) Making lifestyle changes after colorectal cancer: insights for program development Abstract   PDF   HTML
D.L. Dennis, J.L. Waring, N. Payeur, C. Cosby, H. Daudt
Vol 23, No 4 (2016) Making molehills out of a mountain: experience with a new scheduling strategy to diminish workload variations in response to increased treatment demands Abstract   PDF   HTML
A. Waters, M. Alizadeh, C. Filion, F. Ashbury, J. Pun, M.P. Chagnon, A. Legrain, M.A. Fortin
Vol 25, No 2 (2018) Male Oncology Research and Education program for men at high risk for prostate cancer Abstract   PDF   HTML
J. Lorentz, S.K. Liu, D. Vesprini
Vol 17, No 4 (2010) Malignant melanoma metastatic to the larynx: treatment and functional outcome Abstract   PDF
B.G. Lanson, N. Sanfilippo, B. Wang, D. Grew, M.D. DeLacure
Vol 15, No 2 (2008) Malignant Mesothelioma: Canadian Perspective and Research Directions Abstract   PDF
Christopher W Lee
Vol 19, No 5 (2012) Malnutrition screening programs in adult cancer patients: clinical practice is hungry for evidence Details   PDF   HTML
K. Biggs
Vol 22, No 5 (2015) Mammography, Martin Yaffe, and me: response and appreciation Abstract   PDF   HTML
C. Kaniklidis
Vol 22, No 6 (2015) Management and outcomes of localized esophageal and gastroesophageal junction cancer in older patients Abstract   PDF   HTML   CORRIGENDUM
X. Qu, J. Biagi, A. Banashkevich, C.D. Mercer, L. Tremblay, A. Mahmud
Vol 19, No 4 (2012) Management of a suspicious adnexal mass: a clinical practice guideline Abstract   PDF   HTML
J. E. Dodge, A L. Covens, C. Lacchetti, L. M. Elit, T. Le, M. Fung-Kee-Fung, M. Devries–Aboud, Gynecology Cancer Disease Site Group
Vol 17, No 1 (2010) Management of aromatase inhibitor-induced arthralgia Abstract   PDF
J. Younus, L. Kligman
Aromatase Inhibitor Supplement, 2007 Management of Arthralgias Associated with Aromatase Inhibitor Therapy Details   PDF
Carter Thorne
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Management of castration-resistant prostate cancer: a global approach Abstract   PDF   HTML
F. Saad
Vol 21, No 6 (2014) Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors Abstract   PDF   HTML
V. Hirsh, N. Blais, R. Burkes, S. Verma, K. Croitoru
Vol 22, No 2 (2015) Management of egfr tki–induced dermatologic adverse events Abstract   PDF   HTML
B. Melosky, N.B. Leighl, J. Rothenstein, R. Sangha, D. Stewart, K. Papp
Vol 24, No 2 (2017) Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective Abstract   PDF   HTML
M. Cabanero, R. Sangha, B.S. Sheffield, M. Sukhai, M. Pakkal, S. Kamel-Reid, A. Karsan, D. Ionescu, R.A. Juergens, C. Butts, M.S. Tsao
Vol 17, No 1 (2010) Management of hot flashes in women with breast cancer  Abstract   PDF
L. Kligman, J. Younus
Vol 21, No 4 (2014) Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations Abstract   PDF   HTML
J. Boulanger, J.N. Boursiquot, G. Cournoyer, J. Lemieux, M.S. Masse, K. Almanric, M.P. Guay, the Comité de l’évolution des pratiques en oncologie
Vol 20, No 4 (2013) Management of penoscrotal extramammary Paget disease: case series and review of the literature Abstract   PDF   HTML
P. Moretto, V.J. Nair, S. El Hallani, S. Malone, E. Belanger, C. Morash, C.M. Canil
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Management of prostate cancer: Canadian contribution to the changing landscape Abstract   PDF
F. Saad
Vol 20, No 3 (2013) Management of renal collecting duct carcinoma: a systematic review and the McMaster experience Abstract   PDF   HTML
S. Dason, C. Allard, A. Sheridan-Jonah, J. Gill, H. Jamshaid, T. Aziz, B. Kajal, A. Kapoor
Aromatase Inhibitor Supplement, 2007 Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy Details   PDF
Stacy Elliott, Wendy Lam, Christine Derzko
Vol 14, No 4 (2007) Management of Single Brain Metastases: A Practice Guideline Details   PDF
Arlan Mintz, James Perry, Karen Spithoff, Alexandra Chambers, Normand Laperriere
Barb Melosky, Ron Burkes, Daniel Rayson, Thierry Alcindor, Neil Shear, Mario Lacouture
Vol 23, No 3 (2016) Management of small-cell lung cancer with radiotherapy—a pan-Canadian survey of radiation oncologists Abstract   PDF   HTML
J. Shahi, J.R. Wright, Z. Gabos, A. Swaminath
Vol 16 (2009): Renal Cell Carcinoma Supplement Management of toxicities and optimal dosing of targeted drugs in advanced kidney cancer Abstract   PDF
Bostjan Seruga, Hui K. Gan, Jennifer J. Knox
Vol 23, No 1 (2016) Management of uveal melanoma: a consensus-based provincial clinical practice guideline Abstract   PDF   HTML
E. Weis, T.G. Salopek, J.G. McKinnon, M.P. Larocque, C. Temple-Oberle, T. Cheng, J. McWhae, R. Sloboda, M. Shea-Budgell
Vol 15, No 2 (2008) Managing the Toxicities of the FEC-100 followed by Docetaxel Regimen: The Price of Success. Details   PDF
Kara Laing
Vol 18, No 3 (2011) Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancer Abstract   PDF   HTML
V. Hirsh
Vol 21, No 1 (2014) Managing treatment–related adverse events associated with Alk inhibitors Abstract   PDF   HTML
J.M. Rothenstein, N. Letarte
Vol 20, No 2 (2013) Many mosaic mutations Details   PDF   HTML
W.D. Foulkes, F.X. Real
Vol 14, No 2 (2007) Massage Therapy for Cancer Patients: A Reciprocal Relationship Between Body and Mind Details   PDF
Stephen Sagar, Trish Dryden, Raimond K Wong
Vol 26, No 4 (2019) Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making Abstract   PDF   HTML   Supplemental Material
J. Gu, M. Delisle, R. Engler-Stringer, G. Groot
Going Beyond Efficacy Matters of the Heart: Cardiac Toxicity of Adjuvant Systemic Therapy for Early Stage Breast Cancer Details   PDF
Sunil Verma, Phil Bedard, Kathryn Towns
Vol 13, No 3 (2006) Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer - A Systematic Review Details   PDF
Himu Lukka, Tricia Waldron, Laurence Klotz, Eric Winquist, John Trachtenberg
Vol 21, No 5 (2014) Meaningful patient representation informing Canada’s cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review Abstract   PDF   HTML
J.S. Hoch, M.B. Brown, C. McMahon, J. Nanson, L. Rozmovits
Vol 26, No 3 (2019) Measuring colposcopy quality in Canada: development of population-based indicators Abstract   PDF   Supplemental Material   HTML
K. Decker, N. Baines, C. Muzyka, M. Lee, M. H. Mayrand, H. Yang, S. Fung, D. Mercer, S. McFaul, R. Kupets, R. Savoie, R. Lotocki, J. Bentley
Vol 20, No 4 (2013) Measuring concordance with guidelines for the diagnosis and treatment of colon cancer Abstract   PDF   HTML
R. Rahal, J. Klein–Geltink, T. Forte, G. Lockwood, H. Bryant
Vol 25, No 2 (2018) Measuring patient-reported outcomes to improve cancer care in Canada: an analysis of provincial survey data Abstract   PDF   HTML
K. Tran, S. Zomer, J. Chadder, C. Earle, S. Fung, J. Liu, C. Louzado, R. Rahal, R. Shaw Moxam, E. Green
Vol 24, No 2 (2017) Measuring quality care in localized renal cell cancer: use of appropriate preoperative investigations in a population-based cohort Abstract   PDF   HTML
N. Moideen, K.H. Marzouk, K.J. Matheson, L.A. Wood
Vol 25, No 5 (2018) Medical assistance in dying for cancer patients one year after legalization: a collaborative approach at a comprehensive cancer centre Abstract   PDF   HTML
J. S.Y. Wu, J. Pinilla, M. Watson, S. Verma, I. A. Olivotto
Vol 25, No 3 (2018) Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care Abstract   PDF   HTML
A. Fundytus, W.M. Hopman, N. Hammad, J.J. Biagi, R. Sullivan, V. Vanderpuye, B. Seruga, G. Lopes, M. Sengar, M.D. Brundage, C.M. Booth
Vol 13, No 2 (2006) Medical Physics for the Journal Current Oncology Details   PDF
Jan Seuntjens
Vol 19, No 1 (2012) Medullary thyroid cancer and pseudocirrhosis: case report and literature review Abstract   PDF   HTML
B. L. Harry, M.L. Smith, J.R. Burton Jr, A. Dasari, S.G. Eckhardt, J.R. Diamond
Vol 26, No 5 (2019) Medullary Thyroid Introduction Abstract   PDF   HTML
M. K. Gupta
Vol 17, No 3 (2010) Medulloblastoma in infants: the critical issues of the dilemma Abstract   PDF
E. Bouffet
Vol 20, No 6 (2013) Meeting the health information needs of prostate cancer patients using personal health records Abstract   PDF   HTML
H.H. Pai, F. Lau, J. Barnett, S. Jones
Vol 24, No 2 (2017) Meeting the needs of the aging population: the Canadian Network on Aging and Cancer—report on the first Network meeting, 27 April 2016 Abstract   PDF   HTML
M.T.E. Puts, T. Hsu, E. Szumacher, S. Sattar, S. Toubasi, C. Rosario, E. Brain, W. Duggleby, C. Mariano, S. Mohile, H. Muss, M. Trudeau, D. Wan-Chow-Wah, C. Wong, S. Alibhai
Vol 26, No 5 (2019) Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline Abstract   PDF   Supplemental Material   HTML
S. Latosinsky, B. Allen, S. Z. Shariff
Vol 19, No 6 (2012) Melanoma prevention: are we doing enough? A Canadian perspective Abstract   PDF   HTML
A.M. Joshua
Vol 24, No 6 (2017) Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuation Abstract   PDF   HTML
T.P. Hanna, T. Baetz, J. Xu, Q. Miao, C.C. Earle, Y. Peng, C.M. Booth, T.M. Petrella, D. McKay, P. Nguyen, H. Langley, E. Eisenhauer
Vol 25, No 1 (2018) Merkel cell carcinoma masquerading as cellulitis: a case report and review of the literature Abstract   PDF   HTML
F. Safa, M. Pant, C. Weerasinghe, R. Felix, T. Terjanian
Vol 22, No 3 (2015) Message from the Publisher Abstract   PDF   HTML
Multimed Inc.
Vol 21, No 2 (2014) Metabolic syndrome–related hepatocellular carcinoma treated by volumetric modulated arc therapy Abstract   PDF   HTML
J. Klein, L.A. Dawson, T.H. Tran, O. Adeyi, T. Purdie, M. Sherman, A. Brade
Vol 26, No 1 (2019) Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy Abstract   PDF   HTML
M. Dosani, R. Yang, M. McLay, D. Wilson, M. Liu, C. J. Yong-Hing, J. Hamm, C. R. Lund, R. Olson, D. Schellenberg
Vol 20, No 6 (2013) Metaphors and malignancy: making sense of cancer Abstract   PDF   HTML
G. Nicholas
Vol 17, No 6 (2010) Metastatic carcinoid presenting as a breast lesion Abstract   PDF
H.L. Geyer, J. Viney, N. Karlin
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice Metastatic colorectal cancer: therapeutic options for treating refractory disease Abstract   PDF   HTML
A. Parmar, K. K.W. Chan, Y.J. Ko
Vol 17, No 1 (2010) Metastatic lung adenocarcinoma in a 20-year-old patient Abstract   PDF
O. Khan, W.P. Tong, N.J. Karlin
Vol 21, No 3 (2014) Metastatic renal cell carcinoma without evidence of a primary renal tumour Abstract   PDF   HTML
R.M. Kumar, T. Aziz, H. Jamshaid, J. Gill, A. Kapoor
Vol 24, No 2 (2017) Metformin and breast cancer stage at diagnosis: a population-based study Abstract   PDF   HTML
I.C. Lega, K. Fung, P.C. Austin, L.L. Lipscombe
Vol 23, No 3 (2016) Metronomic Chemotherapy and Palliative Radiotherapy as Salvage Treatment of Refractory or Relapsed Pediatric Solid Tumors Abstract   PDF   HTML
A.M. Ali, M.I. El-Sayed
Vol 23, No 3 (2016) Metronomic chemotherapy with 5-fluorouracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer Abstract   PDF   HTML
S. Yang, S. Li, H. Yu, S. Li, W. Liu, X. Liu, H. Ma
O.Graciela Scharovsky, Leandro E. Mainetti, Viviana R. Rozados
Vol 16, No 4 (2009) Microbes and Colorectal Cancer: Is There a Relationship? Abstract   PDF
Christian Jobin, Joshua M Uronis
Vol 23, No 2 (2016) MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case–control study Abstract   PDF   HTML
R. Razzak, E.L.R. Bédard, J.O. Kim, S. Gazala, L. Guo, S. Ghosh, A. Joy, T. Nijjar, E. Wong, W.H. Roa
Vol 17, No 1 (2010) MicroRNA let-7: an emerging next-generation cancer therapeutic Abstract   PDF
D. Barh, R. Malhotra, B. Ravi, P. Sindhurani
Vol 16, No 3 (2009) Might positron emission tomography actually treat micrometastatic cancer? Abstract   PDF
Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Vol 19, No 5 (2012) Mindfulness-based stress reduction for breast cancer— a systematic review and meta-analysis Abstract   PDF   HTML
H. Cramer, R. Lauche, A. Paul, G. Dobos
Vol 14, No 6 (2007) Minds That Matter: 2007 Gairdner International Awards Lectures Details   PDF
Flora Krasnoshtein, Nikolai Nikolov
Vol 18, No 6 (2011) Mixing drinks and concocting troubles Abstract   PDF   HTML
L. Z. G. Touyz
Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer Models of care for early-stage breast cancer in Canada Abstract   PDF   HTML
Y. Madarnas, A. A. Joy, S. Verma, S. Sehdev, W. Lam, L. Sideris
Vol 19, No 3 (2012) Moderators of psychological recovery from benign cancer screening results Abstract   PDF   HTML
M. Pelletier, B. Knäuper, C. G. Loiselle, R. Perreault, C. Mizrahi, L. Dubé
Vol 24, No 3 (2017) Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma Abstract   PDF   HTML
B. Domingo-Arrué, R. Gil-Benso, J. Megías, L. Navarro, T. San-Miguel, L. Muñoz-Hidalgo, C. López-Ginés, M. Cerdá-Nicolás
Vol 26 (2019): A fresh look at Therapeutic Advances in Soft-tissue Sarcoma Molecular targets and novel therapeutic avenues in soft tissue sarcoma Abstract   PDF   HTML
A. Elkrief, T. Alcindor
Vol 18, No 2 (2011) Monitoring response and resistance to treatment in chronic myeloid leukemia Abstract   PDF   HTML
S. Assouline, J. H. Lipton
Vol 15, No 1 (2008) Moses Judah Folkman 1933–2008 Details   PDF
Phil Gold
Vol 24, No 1 (2017) Moving guidelines into action: a report from Cancer Care Ontario’s event Let’s Get Moving: Exercise and Rehabilitation for Cancer Patients Abstract   PDF   HTML
J. Tomasone, C. Zwaal, G.M. Kim, D. Yuen, J. Sussman, R. Segal, on behalf of the Psychosocial Oncology and Survivorship Programs at Cancer Care Ontario
Vol 25, No 6 (2018) Moving research into practice: summary report of the Ex/Cancer meeting on physical activity, exercise, and rehabilitation in oncology Abstract   PDF   HTML
D. Santa Mina, A. J. Fong, A. R. Petrella, S. N. Culos-Reed, M. Chasen, C. M. Sabiston
Vol 26, No 2 (2019) Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines Abstract   PDF   HTML
A. Smith, N. Baines, S. Memon, N. Fitzgerald, J. Chadder, C. Politis, E. Nicholson, C. Earle, H. Bryant
Vol 16 (2009): Renal Cell Carcinoma Supplement mTOR Inhibition in Kidney Cancer Abstract   PDF
Anil Kapoor
Vol 20, No 1 (2013) Multidisciplinary assessment of fitness to drive in brain tumour patients in southwestern Ontario: a grey matter Abstract   PDF   HTML
E. Chan, A.V. Louie, M. Hanna, G.S. Bauman, B.J. Fisher, D.A. Palma, G.B. Rodrigues, A. Sathya, D.P. D'Souza
Vol 18, No 5 (2011) Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Abstract   PDF   HTML
M. Sherman, K. Burak, J. Maroun, P. Metrakos, J. J. Knox, R. P. Myers, M. Guindi, G. Porter, J. R. Kachura, P. Rasuli, S. Gill, P. Ghali, P. Chaudhury, J. Siddiqui, D. Valenti, A. Weiss, R. Wong
Vol 26, No 3 (2019) Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes Abstract   HTML   Supplemental Material   PDF
J. Shao, M. Rodrigues, A. L. Corter, N. N. Baxter
Vol 19, No 4 (2012) Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature Abstract   PDF   HTML
J. M. Croke, S. El-Sayed
Vol 24, No 3 (2017) Multidisciplinary retroperitoneal and pelvic soft-tissue sarcoma case conferences: the added value that radiologists can provide Abstract   PDF   HTML
R.S. Lim, A.Z. Kielar, R.H. El-Maraghi, M.A. Fraser, C. Nessim, S. Thipphavong
Vol 24, No 2 (2017) Multigene expression profile testing in breast cancer: is there a role for family physicians? Abstract   PDF   HTML
M.A. O'Brien, J.C. Carroll, D.P. Manca, B. Miedema, P.A. Groome, T. Makuwaza, J. Easley, N. Sopcak, L. Jiang, K. Decker, M.L. McBride, R. Moineddin, J.A. Permaul, R. Heisey, E.A. Eisenhauer, M.K. Krzyzanowska, S. Pruthi, C. Sawka, N. Schneider, J. Sussman, R. Urquhart, C. Versaevel, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Multimodal approaches to high-risk prostate cancer Abstract   PDF
A. Koupparis, M.E. Gleave
Vol 20, No 6 (2013) Multimodal cancer care research Abstract   PDF   HTML
N. MacDonald
Vol 17, No 3 (2010) Multimodality breast cancer screening in women with a familial or genetic predisposition Abstract   PDF
I. Trop, L. Lalonde, M.H. Mayrand, J. David, N. Larouche, D. Provencher
Vol 25, No 6 (2018) Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV Abstract   PDF   HTML
J. Chen, V. Mehraj, J. Szabo, B. Routy, R. P. Michel, J. P. Routy
Vol 26, No 6 (2019) Multiplicity and the marginal benefits of bevacizumab in malignant solid tumours Abstract   PDF   HTML
N. D. Gay, D. Tao, V. Prasad
Vol 24, No 1 (2017) Nasopharyngeal non-intestinal-type adenocarcinoma: a case report and updated review of the literature Abstract   PDF   HTML
C. Jain, L. Caulley, K.I. Macdonald, B. Purgina, C.K. Lai, B. Esche, S. Johnson-Obaseki
Vol 13, No 1 (2006) Natural Health Products that Inhibit Angiogenesis: Part 1 Details   PDF
Stephen Mark Sagar, Donald Yance
Vol 13, No 3 (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer?Part 2 Details   PDF
Stephen Sagar
901 - 1000 of 1728 Items << < 5 6 7 8 9 10 11 12 13 14 > >>